share_log

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K：員工持股年度報告
美股sec公告 ·  06/25 16:26
Moomoo AI 已提取核心訊息
Bristol-Myers Squibb Company (BMY.US), a leading pharmaceutical company, has filed its annual Form 11-K report with the Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report, signed on June 25, 2024, by Senior Vice President and Treasurer Sandra Ramos-Alves, includes comprehensive financial statements for the Bristol-Myers Squibb Company Savings and Investment Program. The audited financial statements reveal that the net assets available for benefits increased significantly from $8,960,971 in 2022 to $10,303,645 in 2023. The report also details the Program's investment in participant-directed investments, employer contributions, and participant loans. The Program, which is a defined contribution retirement plan, includes a variety of investment options and is subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA). The independent audit, conducted by Withum Smith + Brown, PC, concluded that the financial statements present fairly the net assets and changes in net assets for the year in conformity with U.S. generally accepted accounting principles.
Bristol-Myers Squibb Company (BMY.US), a leading pharmaceutical company, has filed its annual Form 11-K report with the Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report, signed on June 25, 2024, by Senior Vice President and Treasurer Sandra Ramos-Alves, includes comprehensive financial statements for the Bristol-Myers Squibb Company Savings and Investment Program. The audited financial statements reveal that the net assets available for benefits increased significantly from $8,960,971 in 2022 to $10,303,645 in 2023. The report also details the Program's investment in participant-directed investments, employer contributions, and participant loans. The Program, which is a defined contribution retirement plan, includes a variety of investment options and is subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA). The independent audit, conducted by Withum Smith + Brown, PC, concluded that the financial statements present fairly the net assets and changes in net assets for the year in conformity with U.S. generally accepted accounting principles.
領先的藥品公司施貴寶公司 (BMY.US) 已經提交了其2023財年的年度基本報表 (Form 11-K報告) 給美國證券交易委員會。該報告於2024年6月25日由高級副總裁兼財務主管桑德拉·拉莫斯-阿爾維斯簽署，幷包括了施貴寶公司儲蓄和投資計劃的全面財務報表。經審計的財務報表顯示，可供福利使用的淨資產從2022年的8960971美元增加到了2023年的10303645美元。該報告還詳細介紹了該計劃對參與者指導性投資、僱主貢獻和參與者貸款的投資。該計劃是一項明確的退休金計劃，幷包括各種投資選項，並受到1974年僱員退休收入安全法案 (ERISA)的規定。由Withum Smith+Brown公司進行的獨立審計得出結論：財務報表遵循美國普遍接受的會計準則，公正地呈現了淨資產和淨資產變動的情況。
領先的藥品公司施貴寶公司 (BMY.US) 已經提交了其2023財年的年度基本報表 (Form 11-K報告) 給美國證券交易委員會。該報告於2024年6月25日由高級副總裁兼財務主管桑德拉·拉莫斯-阿爾維斯簽署，幷包括了施貴寶公司儲蓄和投資計劃的全面財務報表。經審計的財務報表顯示，可供福利使用的淨資產從2022年的8960971美元增加到了2023年的10303645美元。該報告還詳細介紹了該計劃對參與者指導性投資、僱主貢獻和參與者貸款的投資。該計劃是一項明確的退休金計劃，幷包括各種投資選項，並受到1974年僱員退休收入安全法案 (ERISA)的規定。由Withum Smith+Brown公司進行的獨立審計得出結論：財務報表遵循美國普遍接受的會計準則，公正地呈現了淨資產和淨資產變動的情況。
有用
沒用

該公告為獨立文件：

獨立文件1

獨立文件2

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息